Bard Faces Future after Cisson Verdict

In 2012, Bard lost its first vaginal mesh case and was ordered to pay $3.6 million following the California state court jury's decision.  On August 15, 2013, a West Virginia jury ordered Bard to pay $2 million to Donna Cisson for her injuries due to her use of what the jury found to be the [...]

August 19th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Bard Faces Future after Cisson Verdict

Cisson vs. Bard: $2 Million Victory for Donna Cisson

On August 15, 2013, after about 12 hours of deliberation, the jury found for Donna Cisson in her vaginal mesh trial against manufacturer C.R.Bard Inc, and found damages in the amount of $250,000 and $1.75 million in punitive damages.  The jury found that Bard failed to provide adequate warnings as to the defects in its [...]

August 15th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Cisson vs. Bard: $2 Million Victory for Donna Cisson

A Review of Testimony and Documents presented in Donna Cisson vs. C.R. Bard Avaulta Trial

During the first days of testimony, Plaintiff’s attorneys were building the case that the Bard Avaulta is defective and the warnings are inadequate.  The following is a review of some of the testimony and evidence presented from live and videotaped witnesses as reported from various outlets.  It should be noted that we are focusing on [...]

August 13th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on A Review of Testimony and Documents presented in Donna Cisson vs. C.R. Bard Avaulta Trial

Mesh Mistrial; New Trial Starts July 29, 2013

U.S. District Judge Joseph Goodwin declared the mistrial last week after determining that jurors would not be able to disregard improper testimony by a plaintiff's witness Dr. Lennox Hoyte had testified that no one implants or sells the mesh anymore. The answer was given in response to a Plaintiff’s attorney question: 'What body of evidence [...]

July 17th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Mesh Mistrial; New Trial Starts July 29, 2013

Ethicon Gynecare Trial Cases to be Selected on July 25, 2013

On July 25, 2013, Judge Joseph Goodwin will hear presentations submitted by counsel for consideration for selection as bellwether cases in the Johnson & Johnson Ethicon Gynecare transvaginal mesh cases.  Based on this procedure, Judge Goodwin will then select which cases will then be tried.  It is expected that he will select 5 cases from [...]

June 20th, 2013|Transvaginal Mesh|Comments Off on Ethicon Gynecare Trial Cases to be Selected on July 25, 2013

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]

May 28th, 2013|Actos Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Vaginal Mesh and Litigation Status

As a result of numerous suits filed by women for injuries sustained from transvaginal mesh, the Federal Court system placed these cases in a consolidated system and the MDL panel assigned these cases to U.S. District Court for the Southern District of West Virginia under Chief Judge Joseph R. Goodwin. Judge Goodwin was appointed a [...]

May 14th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Vaginal Mesh and Litigation Status

Risperdal adds to DePuy and Ethicon Troubles for J&J

Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its antipsychotic drug Risperdal.  The drug was approved in 1993 for use in adults and was also later [...]

May 12th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Risperdal adds to DePuy and Ethicon Troubles for J&J

Vaginal Mesh and Pelvic Prolapse

Many of the women who received vaginal mesh did so because of a condition known as Pelvic Prolapse.  Some of the women were not fully aware of non-surgical alternatives or treatments for this condition.  The FDA has information on this condition, which is excerpted in parts below. What is Pelvic Organ Prolapse? Pelvic organ prolapse [...]

May 9th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Vaginal Mesh and Pelvic Prolapse

FDA Reviews of Vaginal Mesh

As many women injured by vaginal mesh unfortunately already know, these devices can lead to dramatic and heartbreaking consequences, severe physical pain, real emotional distress, and be a catalyst in the destruction of intimate relationships. In this blog we review a little of the history and actions by the FDA. WHAT IS VAGINAL MESH? Vaginal [...]

May 6th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on FDA Reviews of Vaginal Mesh